AI Technology Democratising Access to Clinical Trials

In the third episode of Narratives of Purpose's special series on Advancing Women's Health, host Claire Murigande explores the intersection of AI and women's health with Danielle Ralic, CEO and founder of Ancora.ai.

Ancora, an AI-powered clinical trial matching platform, aims to democratise access to trials and accelerate research.

Danielle and Claire discuss the healthcare system's shortcomings in serving women, particularly in clinical trials. The conversation also touches on the broader implications of gender inclusivity in AI and the startup ecosystem, emphasising the need for more support for women-led ventures in healthcare innovation.

Be sure to visit our podcast website for the full episode transcript.

References for content mentioned in this episode:

• Gender bias in medicine article
• Gender funding gap data by UBS

RELEVANT LINKS:

• More about Ancora at this website
• Follow Ancora: LinkedIn | YouTube | Instagram | Facebook
• Connect with our guest, Danielle Ralic: LINKEDIN

Follow our host: WEBSITE | LINKEDIN

Follow us: LinkedIn | Instagram

Connect with us: [email protected] | subscribe to our news

Tell us what you think: write a review

This special series on Advancing Women's Health with Female Founders is supported by TechFace, Lean In Switzerland, and Ladies Drive.

CHAPTERS:

00:00 Episode Introduction

00:42 The Critical Role of Women in Clinical Trials

01:32 Introducing the Host and the Podcast

02:26 The Genesis of Ancora.ai

04:16 The Power of AI in Democratising Clinical Trials

06:23 Ancora's Dual Approach for Patients and Physicians

07:55 The Impact and Evolution of Ancora

11:08 Advocating for Women's Health and Inclusion in AI

13:23 The Future of Women in Tech and Healthcare Innovation

14:49 Closing Remarks and Further Resources